Maze Therapeutics (MAZE) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $27.53, +0.18% vs the prior close of $27.48.
- Volume 1.02M shares, 1.5x its 50-day average.
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
MAZE ends flat (+0.2%) to $27.53. Closed at $27.53, +0.18% vs the prior close of $27.48. Day range $26.72–$27.89, opened at $27.50.
MAZE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MAZE ends flat (+0.2%) to $27.53
- Closed at $27.53, +0.18% vs the prior close of $27.48. Day range $26.72–$27.89, opened at $27.50.
- Volume was 1.02M shares, 1.5x its 50-day average of 658.94K.
- Price is +2.7% vs its 50-day average ($26.81) and -14.7% vs its 200-day average ($32.28).
- 52-week range $21.95–$53.65; today's close sits at 18% of that range, 48.7% below the 52-week high.
Oct 15, 2026 — MAZE jumps 4.8% to $27.48
- Closed at $27.48, +4.77% vs the prior close of $26.23. Day range $26.46–$28.10, opened at $26.59.
- Volume was 540.00K shares, 0.8x its 50-day average of 653.22K.
- Price is +2.4% vs its 50-day average ($26.83) and -15.0% vs its 200-day average ($32.34).
- 52-week range $21.95–$53.65; today's close sits at 17% of that range, 48.8% below the 52-week high.
Oct 14, 2026 — MAZE dips 1.6% to $26.23
- Closed at $26.23, -1.61% vs the prior close of $26.66. Day range $25.97–$27.08, opened at $26.51.
- Volume was 835.70K shares, 1.3x its 50-day average of 643.86K.
- Price is -2.3% vs its 50-day average ($26.84) and -19.1% vs its 200-day average ($32.40).
- 52-week range $21.95–$53.65; today's close sits at 14% of that range, 51.1% below the 52-week high.
Oct 13, 2026 — MAZE slides 3.8% to $26.66
- Closed at $26.66, -3.75% vs the prior close of $27.70. Day range $26.57–$28.24, opened at $27.54.
- Volume was 615.10K shares, 1.0x its 50-day average of 637.82K.
- Price is -0.8% vs its 50-day average ($26.86) and -17.9% vs its 200-day average ($32.48).
- 52-week range $21.95–$53.65; today's close sits at 15% of that range, 50.3% below the 52-week high.
Oct 12, 2026 — MAZE rises 2.2% to $27.70 on 2.3x normal volume
- Closed at $27.70, +2.18% vs the prior close of $27.11. Day range $26.66–$29.32, opened at $27.11.
- Volume was 1.44M shares, 2.3x its 50-day average of 615.78K — unusually heavy trading.
- Price is +3.1% vs its 50-day average ($26.88) and -14.9% vs its 200-day average ($32.56).
- 52-week range $21.95–$53.65; today's close sits at 18% of that range, 48.4% below the 52-week high.
Oct 9, 2026 — MAZE jumps 4.8% to $27.11
- Closed at $27.11, +4.75% vs the prior close of $25.88. Day range $25.88–$27.19, opened at $25.88.
- Volume was 670.90K shares, 1.1x its 50-day average of 609.06K.
- Price is +0.9% vs its 50-day average ($26.86) and -16.9% vs its 200-day average ($32.63).
- 52-week range $21.95–$53.65; today's close sits at 16% of that range, 49.5% below the 52-week high.
Oct 8, 2026 — MAZE dips 1.4% to $25.88, 6 down days in a row
- Closed at $25.88, -1.41% vs the prior close of $26.25. Day range $25.05–$26.44, opened at $25.97.
- Volume was 903.00K shares, 1.5x its 50-day average of 597.18K.
- Price is -3.7% vs its 50-day average ($26.87) and -20.9% vs its 200-day average ($32.71).
- 52-week range $21.95–$53.65; today's close sits at 12% of that range, 51.8% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — MAZE dips 0.7% to $26.25, 5 down days in a row
- Closed at $26.25, -0.68% vs the prior close of $26.43. Day range $25.87–$26.89, opened at $26.30.
- Volume was 823.90K shares, 1.4x its 50-day average of 588.37K.
- Price is -2.4% vs its 50-day average ($26.90) and -19.9% vs its 200-day average ($32.79).
- 52-week range $21.95–$53.65; today's close sits at 14% of that range, 51.1% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — MAZE ends flat (+0.0%) to $26.43, 4 down days in a row
- Closed at $26.43, +0.00% vs the prior close of $26.43. Day range $25.78–$26.91, opened at $26.74.
- Volume was 682.80K shares, 1.2x its 50-day average of 580.11K.
- Price is -1.9% vs its 50-day average ($26.93) and -19.6% vs its 200-day average ($32.86).
- 52-week range $21.95–$53.65; today's close sits at 14% of that range, 50.7% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — MAZE ends flat (+0.0%) to $26.43, 3 down days in a row
- Closed at $26.43, +0.00% vs the prior close of $26.43. Day range $25.78–$27.03, opened at $26.67.
- Volume was 588.00K shares, 1.0x its 50-day average of 571.67K.
- Price is -2.0% vs its 50-day average ($26.98) and -19.7% vs its 200-day average ($32.92).
- 52-week range $21.95–$53.65; today's close sits at 14% of that range, 50.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — MAZE dips 0.8% to $26.43
- Closed at $26.43, -0.83% vs the prior close of $26.65. Day range $26.36–$27.49, opened at $27.08.
- Volume was 633.00K shares, 1.1x its 50-day average of 566.00K.
- Price is -2.1% vs its 50-day average ($27.00) and -19.9% vs its 200-day average ($32.99).
- 52-week range $21.95–$53.65; today's close sits at 14% of that range, 50.7% below the 52-week high.
MAZE latest news & SEC filings
Every SEC filing by or about MAZE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Coloma Jason V sold 2,593 shares at $27.02 (≈$70.07K) on Oct 1, 2026; now holds 15,558
- Coloma Jason V sold 31,908 shares at $27.02 (≈$862.19K) on Oct 1, 2026; now holds 191,447
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bernstein Harold converted options/RSUs into 16,141 shares at $10.42 (≈$168.19K) on Oct 1, 2026; now holds 16,141
- Bernstein Harold sold 16,141 shares at $26.93 (≈$434.74K) on Oct 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dandekar Atul converted options/RSUs into 7,500 shares at $10.42 (≈$78.15K) on Sep 29, 2026; now holds 39,816
- Dandekar Atul sold 7,500 shares at $27.06 (≈$202.92K) on Sep 29, 2026; now holds 32,316
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bernstein Harold sold 9,705 shares at $26.22 (≈$254.47K) on Sep 4, 2026
- Bernstein Harold sold 9,705 shares at $26.22 (≈$254.47K) on Sep 4, 2026
- Bernstein Harold sold 9,705 shares at $26.22 (≈$254.47K) on Sep 4, 2026
- Bernstein Harold sold 9,705 shares at $26.22 (≈$254.47K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$44.73M (prior year -$33.68M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.76 (prior year -$0.77) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MAZE
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 25, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.10% (largest 26.8%). That is a volatile stock.
- Liquidity: about 962.26K shares (≈$26.49M) trade per day on average.
- 52-week position: $27.53 vs a range of $21.95–$53.65 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Harold Bernstein sold 9,705 shares on Sep 4, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Aug 17, 2026; 10-Q Aug 11, 2026.
- Share count: 55.55M shares outstanding (Aug 5, 2026), +26.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
MAZE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 27.50 | 27.89 | 26.72 | 27.53 | 1.02M |
| Oct 15, 2026 | 26.59 | 28.10 | 26.46 | 27.48 | 540.00K |
| Oct 14, 2026 | 26.51 | 27.08 | 25.97 | 26.23 | 835.70K |
| Oct 13, 2026 | 27.54 | 28.24 | 26.57 | 26.66 | 615.10K |
| Oct 12, 2026 | 27.11 | 29.32 | 26.66 | 27.70 | 1.44M |
| Oct 9, 2026 | 25.88 | 27.19 | 25.88 | 27.11 | 670.90K |
| Oct 8, 2026 | 25.97 | 26.44 | 25.05 | 25.88 | 903.00K |
| Oct 7, 2026 | 26.30 | 26.89 | 25.87 | 26.25 | 823.90K |
| Oct 6, 2026 | 26.74 | 26.91 | 25.78 | 26.43 | 682.80K |
| Oct 5, 2026 | 26.67 | 27.03 | 25.78 | 26.43 | 588.00K |
| Oct 2, 2026 | 27.08 | 27.49 | 26.36 | 26.43 | 633.00K |
| Oct 1, 2026 | 27.05 | 27.79 | 26.50 | 26.65 | 589.30K |
| Sep 30, 2026 | 27.21 | 28.02 | 26.95 | 27.18 | 518.00K |
| Sep 29, 2026 | 26.77 | 27.55 | 26.47 | 27.02 | 709.50K |
| Sep 28, 2026 | 25.97 | 27.73 | 24.84 | 26.85 | 1.18M |
| Sep 25, 2026 | 26.23 | 27.79 | 25.42 | 26.05 | 925.60K |
| Sep 24, 2026 | 28.42 | 28.46 | 25.96 | 26.21 | 789.20K |
| Sep 23, 2026 | 28.30 | 29.91 | 27.53 | 28.09 | 1.70M |
| Sep 22, 2026 | 24.52 | 29.40 | 24.50 | 28.38 | 3.57M |
| Sep 21, 2026 | 22.52 | 23.01 | 21.95 | 22.39 | 517.00K |
About Maze Therapeutics
Maze Therapeutics (MAZE) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1842295.
MAZE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nancy C Andrews | Director | Jun 10, 2026 |
| Jason V Coloma | Chief Executive Officer | Sep 4, 2026 |
| Charles J Homcy | Director | Jun 10, 2026 |
| Herve Hoppenot | Director | Jun 10, 2026 |
| Paula A Johnson | Director | Aug 17, 2026 |
| Sophie Kornowski | Director | Aug 17, 2026 |
| Neil Kumar | Director | Mar 31, 2026 |
| Jonathan E Lim | Director | Jun 10, 2026 |
| Richard H Scheller | Director | Jun 10, 2026 |
| Daniel K Spiegelman | Director | Jun 10, 2026 |
| Catherine A. Sohn | Director | Jan 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Amy Bachrodt | SVP, Finance | Apr 2, 2026 |
| Harold Bernstein | President, R&D & CMO | Sep 8, 2026 |
| Jason V Coloma | Chief Executive Officer | Sep 4, 2026 |
| Phillips Courtney | GC and Corp. Secretary | Sep 4, 2026 |
| Atul Dandekar | CSBO | Sep 4, 2026 |
| Misbah Tahir | Chief Financial Officer | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Harold Bernstein | Sale | 9,705 | $26.22 |
| Sep 4, 2026 | Harold Bernstein | Sale | 9,705 | $26.22 |
| Sep 4, 2026 | Harold Bernstein | Sale | 9,705 | $26.22 |
| Sep 4, 2026 | Harold Bernstein | Sale | 9,705 | $26.22 |
| Sep 3, 2026 | Harold Bernstein | Sale | 59 | $25.78 |
| Sep 3, 2026 | Harold Bernstein | Sale | 5,130 | $26.01 |
| Sep 3, 2026 | Harold Bernstein | Sale | 59 | $25.78 |
| Sep 3, 2026 | Harold Bernstein | Sale | 5,130 | $26.01 |
| Sep 3, 2026 | Harold Bernstein | Sale | 59 | $25.78 |
| Sep 3, 2026 | Harold Bernstein | Sale | 5,130 | $26.01 |
| Sep 3, 2026 | Harold Bernstein | Sale | 59 | $25.78 |
| Sep 3, 2026 | Harold Bernstein | Sale | 5,130 | $26.01 |
| Sep 3, 2026 | Phillips Courtney | Sale | 1,990 | $26.01 |
| Sep 3, 2026 | Phillips Courtney | Sale | 22 | $25.78 |
| Sep 3, 2026 | Phillips Courtney | Sale | 1,990 | $26.01 |
MAZE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-131.12M | -3.05 | $-111.94M |
| Dec 31, 2024 | $167.50M | $52.23M | 1.25 | $75.95M |
Latest balance sheet: total assets $531.62M, total liabilities $78.50M, cash $202.64M (as of Jun 30, 2026).
MAZE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $27.31 |
| May 12, 2026 | 8-K Item 2.02 (results) | $25.78 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $31.73 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $29.63 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $13.74 |
| May 14, 2025 | 8-K Item 2.02 (results) | $9.06 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $11.01 |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MAZE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.